ReviewAnemia2026
Prevalence and Risk Factors of Anemia Among Ethiopian Cancer Patients Undergoing Treatment: A Systematic Review and Meta-Analysis.
Review in Anemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anemia is a prevalent but under-recognized cancer complication, particularly in low-resource countries like Ethiopia. It significantly impacts treatment outcomes, fatigue, quality of life, and mortality rates. This review aims to estimate the prevalence of anemia and its risk factors among cancer patients in Ethiopia for clinical decision-making and public health strategies. Methods: This study employed a systematic review and meta-analysis design, sourcing evidence from various electronic databases until August 03, 2025. The data were extracted from June 01 to 30 and analyzed from July 01 to 25, with report generation till August 03, 2025, using R software. Meta-analysis was performed using a random-effects model, with forest plots illustrating pooled prevalence and associated factors. Heterogeneity was assessed using the I Results: Eleven studies involving diverse cancer populations across Ethiopia were included. The pooled prevalence of anemia among cancer patients was 39.5% (95% CI: 26.9%-52.1%). Advanced cancer stage, female sex, older age, poor nutritional status, rural residence, presence of comorbidities, hematologic malignancies, ≥ six cycles of chemotherapy, bone metastasis, and history of bleeding were factors associated with the development of cancer in patients who received treatment. Conclusion: Anemia is common among Ethiopian cancer patients, driven by both disease- and treatment-related factors. Routine screening and targeted interventions are needed to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.